Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.2K
Overview
51.2K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

920
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
920
Cancer Vaccines01:30

Cancer Vaccines

936
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
936

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RNA methylation: A potential therapeutic target in autoimmune disease.

International reviews of immunology·2023
Same author

Epigenetic induction of lipocalin 2 expression drives acquired resistance to 5-fluorouracil in colorectal cancer through integrin β3/SRC pathway.

Oncogene·2021
Same author

Positive result of Sars-Cov-2 in faeces and sputum from discharged patients with COVID-19 in Yiwu, China.

Journal of medical virology·2020
Same author

The endoplasmic reticulum is a target organelle for trivalent dimethylarsinic acid (DMAIII)-induced cytotoxicity.

Toxicology and applied pharmacology·2012
Same author

(E)-1-{4-[Bis(4-bromo-phen-yl)meth-yl]piperazin-1-yl}-3-(4-eth-oxy-phen-yl)prop-2-en-1-one.

Acta crystallographica. Section E, Structure reports online·2012
Same author

(E)-1-{4-[Bis(4-bromo-phen-yl)meth-yl]piperazin-1-yl}-3-(4-methyl-phen-yl)prop-2-en-1-one.

Acta crystallographica. Section E, Structure reports online·2012

Related Experiment Video

Updated: Jan 10, 2026

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

4.5K

Hepatitis Vaccines: Recent Advances and Challenges.

Mei Lu1, Yakun Liu2, Lele Li1

  • 1Department of Clinical Laboratory, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu 322000, China.

Vaccines
|November 26, 2025
PubMed
Summary

Vaccination is key to controlling viral hepatitis (HAV, HBV, HCV, HDV, HEV). This review covers advancements and challenges in hepatitis vaccines to support global elimination goals.

Keywords:
hepatitis vaccinesimmune evasionimmune responsesinnovative adjuvantsvaccine design

More Related Videos

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

13.9K
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

10.2K

Related Experiment Videos

Last Updated: Jan 10, 2026

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

4.5K
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

13.9K
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

10.2K

Area of Science:

  • Hepatology
  • Immunology
  • Public Health

Background:

  • Viral hepatitis remains a significant global health concern, caused by five main virus types: hepatitis A virus (HAV), hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis D virus (HDV), and hepatitis E virus (HEV).
  • Vaccination is recognized as the most effective and cost-efficient strategy for preventing viral hepatitis and its complications.
  • Extensive vaccination programs for HAV and HBV are implemented in many countries.

Purpose of the Study:

  • To systematically review recent advancements in hepatitis vaccine development.
  • To assess the current status of global vaccination efforts against viral hepatitis.
  • To identify persistent challenges hindering hepatitis vaccine efficacy and coverage.

Main Methods:

  • Systematic literature review of recent advancements in vaccine formulation, adjuvants, and vectors.
  • Analysis of current vaccination coverage data and immune response studies.
  • Evaluation of vaccine safety profiles and ongoing challenges.

Main Results:

  • Biotechnology has driven progress in vaccine design, adjuvants, and vectors.
  • Despite progress, challenges include insufficient vaccination coverage and variable immune responses in certain populations.
  • Concerns regarding vaccine safety require ongoing monitoring and research.

Conclusions:

  • Hepatitis vaccines are crucial tools for controlling viral hepatitis.
  • Addressing challenges in coverage, immune response, and safety is essential for success.
  • These insights aim to support the World Health Organization's 2030 goal for viral hepatitis elimination.